Blog - Frier Levitt Government Affairs

Health Policy Check Up News

Our blog provides timely insight on the latest industry trends. We discuss manufacturing, acute and post-acute care issues.
Stay current with our latest insights.

December 2, 2019

FDA Issues 15 New Warning Letters to CBD Companies and Publishes Consumer Update

November 5, 2019

USDA Establishes Hemp Regulatory Framework

October 23, 2019

The FDA and FTC issue Warning Letter to Florida CBD Company for Unsubstantiated Disease Claims and Marketing to Children

September 20, 2019

Federal Trade Commission Issues New Warning Letters for CBD Products

July 15, 2019

FDA Announces it is Expediting Review of CBD

July 11, 2019

Blog: HHS Announces New Payment Models Impacting Nephrology Stakeholders

HHS Announces New Payment Models Impacting Nephrology Stakeholders

June 20, 2019

FDA Extends Comment Period on Products Containing Cannabis

June 14, 2019

FDA Conducts Anticipated Hearing on the Regulation of CBD Products

June 12, 2019

Service Spotlight: Forming a Political Action Committee (PAC): What the Healthcare and Life Sciences Stakeholders Need to Know

June 6, 2019

Massachusetts Releases PBM Transparency Report